Je veux savoir à propos de…

Federal Register / Vol. 86, No. 151 / Tuesday, August 10, 2021 / Notices 9. TEKTURNA aliskiren hemifumarate 10. VIMOVO naproxen/esomeprazole magnesium 11. VIREAD tenofovir disoproxil fumarate 12. XOFLUZA baloxavir marboxil Center for Devices and Radiological Health 1. CONTEGRA PULMONARY VALVED
CONDUIT Humanitarian Device Exemption HDE
2. ELANA SURGICAL KIT HDE
3. ENTERRA THERAPY SYSTEM HDE
4. LIPOSORBER LA15 SYSTEM HDE
5. MEDTRONIC ACTIVA DYSTONIA
THERAPY HDE
6. MINIMALLY INVASIVE DEFORMITY
CORRECTION MIDC SYSTEM
7. PLEXIMMUNE INVITRO
DIAGNOSTIC TEST HDE
8. PULSERIDER ANEURYSM NECK
RECONSTRUCTION DEVICE HDE
9. THE TETHERVERTEBRAL BODY
TETHERING SYSTEM
Dated: August 5, 2021.
Lauren K. Roth, Acting Principal Associate Commissioner for Policy.
FR Doc. 202117041 Filed 8921; 8:45 am BILLING CODE 416401P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES

Office of the Director, National Institutes of Health; Notice of Meeting Notice is hereby given of a meeting of the HEAL Helping to End Addiction Long-Term Multi-Disciplinary Working Group.
The meeting will be open to the public as indicated below via NIH
Videocast. Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The program documents and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the program documents, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: HEAL MultiDisciplinary Working Group MDWG
Meeting.

VerDate Sep<11>2014

17:05 Aug 09, 2021

Jkt 253001

Date: September 12, 2021.
Open: September 01, 2021, 10:30 a.m. to 11:30 a.m.
Closed: September 02, 2021, 11:30 a.m. to 4:30 p.m.
Closed: September 02, 2021, 10:30 a.m. to 3:45 p.m.
Agenda: Provide an update on Helping to End Addiction Long-Term HEAL Initiative projects and obtain expertise from MDWG
relevant to the NIH HEAL Initiative and to specific HEAL projects.
Videocast: The open portion of the meeting will be live webcast at: https
videocast.nih.gov/.
Place: National Institutes of Health, Building 1, Wilson Hall, 1 Center Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Rebecca G Baker, Ph.D., Office of the Director, National Institutes of Health, 1 Center Drive, Room 103A, Bethesda, MD 20892, 301 4021994, Rebecca.baker@nih.gov.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Information is also available on the Office of the Director for the NIH HEAL Initiative website: https heal.nih.gov/news where an agenda and any additional information for the meeting will be posted when available.
Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS
Dated: August 5, 2021.
Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202117012 Filed 8921; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10a of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Center for Scientific Review Advisory Council.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
URL for virtual access:https
videocast.nih.gov/watch=42556

PO 00000

Frm 00046

Fmt 4703

Sfmt 4703

Name of Committee: Center for Scientific Review Advisory Council.
Date: September 27, 2021.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: Provide advice to the Director, Center for Scientific Review CSR, on matters related to planning, execution, conduct, support, review, evaluation, and receipt and referral of grant applications at CSR.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, Virtual Meeting.
Contact Person: Bruce Reed, Ph.D., Deputy Director, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301 5949159, reedbr@mail.nih.gov.
Information is also available on the Institutes/Centers home page: https
public.csr.nih.gov/AboutCSR/Organization/
CSRAdvisoryCouncil, where an agenda and any additional information for the meeting will be posted when available.
Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333, 93.337, 93.39393.396, 93.83793.844, 93.84693.878, 93.892, 93.893, National Institutes of Health, HHS
Dated: August 5, 2021.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202117043 Filed 8921; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health Notice of Listing of Members of the National Institutes of Healths Senior Executive Service 2021 Performance Review Board PRB
AGENCY:

National Institutes of Health,
HHS.
ACTION:

Notice.

The National Institutes of Health NIH announces the persons who will serve on the National Institutes of Healths Senior Executive Service 2021 Performance Review Board.
FOR FURTHER INFORMATION CONTACT: For further information about the NIH
Performance Review Board, contact Mr.
Kha Nguyen, Director, Division of Senior and Scientific Executive Management, Office of Human Resources, National Institutes of Health, Building 31, Room 1C31P, Bethesda, Maryland 20892, telephone 301.594.3022 not a toll-free number, email kha.nguyen@nih.gov.
SUPPLEMENTARY INFORMATION: This action is being taken in accordance with SUMMARY:

Center for Scientific Review; Notice of Meeting
43669

E:FRFM10AUN1.SGM

10AUN1